MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE

The results of work on identification and registration of complications of medicinal therapy in medical institutions of the Irkutsk region showed that that the frequency of undesirable medicinal reactions in patients made from 10 to 30 %. The standard scheme of antibacterial therapy results in resis...

Full description

Bibliographic Details
Main Authors:	N. V. Verlan, E. O. Kochkina, N. N. Soboleva, O. A. Solodukhina
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2017-02-01
Series:	Acta Biomedica Scientifica
Subjects:	safety monitoring drug adverse drug reaction
Online Access:	https://www.actabiomedica.ru/jour/article/view/363

Similar Items

Clinical and pharmacological monitoring of drug safety in pediatrics
by: N. V. Verlan, et al.
Published: (2016-05-01)

Our experience of monitoring of drugs safety in gerontological practice
by: N. V. Verlan, et al.
Published: (2016-04-01)

Drug Safety for Children — International Monitoring Data for 50 Years
by: B. K. Romanov, et al.
Published: (2019-06-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023-09-01)

Pharmacovigilance: the evolution of drug safety monitoring
by: Muhammad Akhtar Abbas Khan, et al.
Published: (2024-12-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Analysis of Data on Adverse Drug Reactions and Functional Flaws of the Pharmacovigilance System Associated with Self-Treatment with Antibiotics
by: N. V. Verlan, et al.
Published: (2022-10-01)

Off-Label Prescribing in Paediatric Cardiology: Regulatory Aspects and Safety Assessment by Spontaneous Reporting
by: E. O. Kochkina, et al.
Published: (2023-03-01)

DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01)

Empowering Patient Safety: Assessment of Adverse Drug Reaction Knowledge and Practice Among Pharmacy Professionals
by: Josipa Bukić, et al.
Published: (2024-12-01)

Malnutrition in Elderly Patients as a Complication of a Drug Therapy: Clinical Pharmacologist’s Point of View
by: A. P. Pereverzev, et al.
Published: (2019-03-01)

Assessment of Safety Signals for Aztreonam in Different Age Groups: National and International Drug Safety Monitoring
by: E. A. Sokova, et al.
Published: (2022-07-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

Drugs prescribed and adverse drug reaction monitoring in skin diseases
by: Maham Ashraf, et al.
Published: (2020-01-01)

Therapeutic Drugs Monitoring and the Consequences for Health and Well-Being
by: O. O. Edenya, et al.
Published: (2024-10-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

Aspects of the Safe Use of Antibacterial Drugs in Community-Acquired Pneumonia: the Implications of Drug-Drug Interactions
by: A. A. Taube, et al.
Published: (2022-08-01)

Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study
by: Jia Yin Lee, et al.
Published: (2021-12-01)

EVALUATIONS OF ADVERSE DRUGS REACTIONS IN RUSSIA IN 2013
by: V. A. Merkulov, et al.
Published: (2022-05-01)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
by: A. P. Pereverzev, et al.
Published: (2019-12-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

A Drug Safety Surveillance Study of a Ciprofloxacin/Dexamethasone Ophthalmic Fixed Combination in Peruvian Population
by: Homero Contreras-Salinas, et al.
Published: (2021-01-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
by: O. V. Shatalova, et al.
Published: (2015-09-01)

Drug-Induced Neutropenia and Agranulocytosis
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-01-01)

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-02-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
by: Zuzaan Zulzaga, et al.
Published: (2021-12-01)

Lung Injury Induced by Antitumor Drugs: Prevalence, Certain Drugs and Their Mechanisms of Action. Part 2
by: N. V. Orlova, et al.
Published: (2021-09-01)

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms
by: Jinxiang Yang, et al.
Published: (2024-06-01)

USE OF DRUGS DURING THE FIRST TRIMESTER OF PREGNANCY IN TERMS OF FOETUS SAFETY: ANALYSIS OF PRESCRIBINGS
by: A. P. Pereverzev, et al.
Published: (2022-06-01)

Drug-induced parkinsonism
by: T. M. Ostroumova, et al.
Published: (2021-12-01)

Comparative Analysis of Drug Interactions with Antibacterial Agents in the Treatment of Community-Acquired Pneumonia
by: A. A. Taube, et al.
Published: (2021-10-01)

THE SAFETY AND EFFICACY OF RIFAPENTINE USED TO TREAT DRUG-SUSCEPTIBLE PULMONARY TUBERCULOSIS
by: N. V. Litvinova, et al.
Published: (2014-04-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)